Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Danish-Made TB Vaccine Sickens 115 Children in Romania

Don't Miss Out —
Follow us on:

Nov. 23 (Bloomberg) -- More than 100 children in Romania have been sickened by a tuberculosis vaccine made in Denmark, the European Centre for Disease Prevention and Control said in a report on its website today.

The children had symptoms including swollen lymph nodes and abscesses, and 50 of the 115 children have been hospitalized since March, the Stockholm-based ECDC said, citing Romanian media reports. Romanian Health Minister Raed Arafat said in a televised address yesterday that TB vaccinations would stop until the cause of the side effects is determined.

The vaccine was made by Statens Serum Institut, a Copenhagen-based unit of Denmark’s health ministry, Nils Strandberg Pedersen, the institute’s chief executive officer, said by phone today. Lymph node swelling is a “completely normal” side effect of the bacille Calmette-Guerin vaccine that the institute has made for more than 50 years, Pedersen said.

“Whether the number is above the threshold that is normally seen, I cannot say,” Pedersen said, adding that the institute had received “only a few reports of side effects” so far. “Abscesses are more rare, but also seen as a consequence of the vaccine.”

To contact the reporter on this story: Simeon Bennett in Geneva at sbennett9@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.